Participations à des congrès et colloques internationaux (70)

  1. 32. Trepo, E., Degré, D., Pradat, P., Gustot, T., Lemmers, A., Gerkens, A., Ouziel, R., Quertinmont, E., Deltenre, P., Le Moine, O., Devière, J., & Moreno, C. (2011). Insulin resistance but not APOC3 variants confers a higher risk for portal hypertension and cirrhosis in patients with alcoholic liver disease. Poster présenté à la conférence The American association of the study of liver conference (November 2011: San Francisco, United States).
  2. 33. Trepo, E., Degré, D., Lemmers, A., Gustot, T., Gerkens, A., Evrard, S., Ouziel, R., Deltenre, P., Adler, M., Devière, J., & Moreno, C. (2011). Insulin resistance confers a higher risk of portal hypertension, cirrhosis and early mortality to alcoholic liver disease patients. Paper session presented at Belgian Week of Gastroenterology (2011).
  3. 34. Trepo, E., Gustot, T., Pradat, P., Gervy, C., Quertinmont, E., Degré, D., Ouziel, R., Vercruysse, V., Deltenre, P., Franchimont, D., Lemmers, A., Le Moine, O., Gulbis, B., Devière, J., & Moreno, C. (2011). Vitamin D deficiency per se (but not its relative genetic variants) is associated with the severity of alcoholic liver disease. Paper session presented at American Association for the Study of Liver Diseases (AASLD) (2012: San Francisco, USA).
  4. 35. Trepo, E., Pradat, P., Potthoff, A., Gustot, T., Lemmers, A., Quertinmont, E., Berthillon, P., Devière, J., Manns, M., Trepo, C., Wedemeyer, H., Franchimont, D., & Moreno, C. (2011). Impact of PNPLA3 (RS738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. EASL Abstract session presented at (2011: Berlin)
  5. 36. Trepo, E., Gustot, T., Pradat, P., Gervy Decoster, C., Quertinmont, E., Degré, D., Ouziel, R., Vercruysse, V., Deltenre, P., Franchimont, D., Lemmers, A., Le Moine, O., Gulbis, B., Devière, J., & Moreno, C. (2011). Vitamin D deficiency per se (but not its related genetic variants) is associated with the severity of alcoholic liver disease. AASLD Abstract session presented at (San Franscico)
  6. 37. Trepo, E., Degré, D., Lemmers, A., Gustot, T., Gerkens, A., Evrard, S., Ouziel, R., Deltenre, P., Adler, M., Devière, J., & Moreno, C. (2011). Insulin resistance confers a higher risk of portal hypertension, cirrhosis and early mortality to alcoholic liver disease patients. EASL Abstract session presented at (Berlin)
  7. 38. Trepo, E., Degré, D., Pradat, P., Gustot, T., Lemmers, A., Gerkens, A., Ouziel, R., Quertinmont, E., Vercruysse, V., Deltenre, P., Le Moine, O., Devière, J., & Moreno, C. (2011). Insulin resistance but not APOC3 variants confers a higher risk for portal hypertension and cirrhosis in patients with alcoholic liver disease. AASLD Abstract session presented at (San Franscico)
  8. 39. Ouziel, R., Trepo, E., Cremer, A., Moreno, C., Degré, D., Cotton, F., Vercruysse, V., Quertinmont, E., Devière, J., Lemmers, A., & Gustot, T. (2011). All-trans retinoic acid deficiency contributes to the excessive proinflammatory response observed in patients with alcoholic cirrhosis. AASLD Abstract session presented at (San Franscico)
  9. 40. Degré, D., Lemmers, A., Gustot, T., Trepo, E., Ouziel, R., Demetter, P., Verset, L., Quertinmont, E., Vercruysse, V., Le Moine, O., Devière, J., & Moreno, C. (2011). Highly expressed CCL-2 in severe form of alcoholic hepatitis: A potential enhancer of the IL-17-neutrophil recruitment pathway. EASL Abstract session presented at (Berlin)
  10. 41. Gustot, T., Velissaris, D., Njimi, H., Taccone, F., Moreno, C., & Vincent, J. L. (2011). Enhanced sepsis-associated mortality of patients with cirrhosis in ICU: Results from the international EPIC II study. American Association of the Study of Liver Disease Abstract session presented at (2011: San Franscico)
  11. 42. Gustot, T., Velissaris, D., Njimi, H., Taccone, F., Moreno, C., & Vincent, J. L. (2011). Enhanced sepsis-associated mortality of patients with cirrhosis in ICU: results from the international EPIC II study. Paper session presented at Liver meeting: American Association of the Study of Liver Disease (2011: San Francisco).
  12. 43. Gustot, T., Lemmers, A., Moreno, C., Degré, D., Ouziel, R., Franchimont, D., Lebrec, D., Moreau, R., & Devière, J. (2010). Circulating antibodies to commensal bacillus subtilis flagellin as a new biomarker for bacterial translocation-driven increased microbe-host interactions in patients with cirrhosis. Poster présenté à la conférence EASL (avril 2010: Vienne).

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>